Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2021. Start Trial.
Date Value
November 18, 2026 1.745
November 17, 2026 1.800
November 16, 2026 1.883
November 13, 2026 2.040
November 12, 2026 2.021
November 11, 2026 2.167
November 10, 2026 2.078
November 09, 2026 2.082
November 06, 2026 2.044
November 05, 2026 1.877
November 04, 2026 2.048
November 03, 2026 1.994
November 02, 2026 1.897
October 30, 2026 1.985
October 29, 2026 2.132
October 28, 2026 2.157
October 27, 2026 1.995
October 26, 2026 1.84
October 23, 2026 1.802
October 22, 2026 1.977
October 21, 2026 2.105
October 20, 2026 2.185
October 19, 2026 2.050
October 16, 2026 2.025
October 15, 2026 2.147
Date Value
October 14, 2026 2.035
October 13, 2026 2.062
October 12, 2026 2.169
October 09, 2026 2.224
October 08, 2026 2.119
October 07, 2026 2.100
October 06, 2026 2.095
October 05, 2026 2.155
October 02, 2026 2.280
October 01, 2026 2.309
September 30, 2026 2.387
September 29, 2026 1.963
September 28, 2026 1.972
September 25, 2026 1.960
September 24, 2026 1.992
September 23, 2026 2.032
September 22, 2026 2.151
September 21, 2026 2.064
September 18, 2026 2.061
September 17, 2026 1.988
September 16, 2026 1.864
September 15, 2026 1.846
September 14, 2026 1.864
September 11, 2026 1.784
September 10, 2026 1.827

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Agenus, Inc. --
Amgen, Inc. 16.73
Anika Therapeutics, Inc. 1.326
BioCryst Pharmaceuticals, Inc. --
Imunon, Inc. 1.374

Price to Book Value Related Metrics

PS Ratio 7.301
Price 10.46
Earnings Yield -26.69%
Market Cap 589.68M